Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD
Bernhard Scheiner(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), Rosa Johanna Nussbaumer(Medical University of Vienna), Peter Quehenberger, Benedikt Simbrunner(Austrian Academy of Sciences), Cihan Ay(University of North Carolina at Chapel Hill), Lukas Hartl(Medical University of Vienna), Matthias Pinter(Medical University of Vienna), Rafael Paternostro(Medical University of Vienna), Georg Semmler(University of Southern Denmark), Ton Lisman(University Medical Center Groningen), Thomas Reiberger(ERN GUARD-Heart), Albert Friedrich Stättermayer(Medical University of Vienna), Mathias Jachs(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Lorenz Balcar(Medical University of Vienna), Johanna Weinzierl(Medical University of Vienna), David Bauer(Austrian Academy of Sciences)
Cited by 55
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399